Australis Capital Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Stock Symbol
  • AUSA
Stock Symbol
  • Investments
  • 13
  • Share Price
  • $0.29
  • (As of Wednesday Closing)

Australis Capital General Information

Description

Australis Capital Inc is an investment company. It is focused on investments in the cannabis industries in Canada and the United States. The company operates through two operating segments: Cannabis and Technology. The cannabis segment involves production and cultivation operation, construction of a cultivation and manufacturing facility, and minority investments in other cannabis operators. Technology encompasses operations of the Company's subsidiaries, Rthm Technologies, Inc and Cocoon Technology, LLC.

Contact Information

Website
www.ausacap.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Capital Markets/Institutions
Stock Exchange
CNQ
Primary Office
  • 376 East Warm Springs Road
  • Suite 190
  • Las Vegas, NV 89119
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Australis Capital Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.29 $0.29 $0.08 - $0.61 $50.4M 177M 416K -$0.17

Australis Capital Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 16,236 17,281 98,749
Revenue 231 166 99
EBITDA (28,677) (17,648) (3,349) 1
Net Income (29,144) (17,544) (3,178) (33)
Total Assets 32,156 44,916 48,720 2,331
Total Debt 443 530 13 2,429
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Australis Capital Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Australis Capital‘s full profile, request access.

Request a free trial

Australis Capital Executive Team (17)

Name Title Board Seat Contact Info
Terry Booth Chief Executive Officer
Jon Paul Chief Financial Officer
Cleve Tzung Chief Operating Officer
Jason Dyck Chief Science Officer & Scientific Advisory Board
Randon Marcos Director
You’re viewing 5 of 17 executive team members. Get the full list »

Australis Capital Board Members (1)

Name Representing Role Since
00000 0000 Australis Capital Chief Science Officer & Scientific Advisory Board 000 0000
To view Australis Capital’s complete board members history, request access »

Australis Capital Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 11-Mar-2021 000000000000000000 00.00 Pharmaceuticals 00000 00000
000000 0000000 000 09-Mar-2021 000000000000000000 0000 Construction and Engineering 0000 00
00000000000000000 03-Mar-2021 00000 0000000 Other Commercial Services 0000 00
0000000 00000000 0 25-Jun-2020 000000000000000000 000.00 Other Financial Services 00000 00000
Folium Biosciences 01-Jan-2020 Reverse Merger Biotechnology
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Australis Capital Subsidiaries (3)

Company Name Industry Location Founded
Aurora Larssen Projects Construction and Engineering Burlington, Canada 2017
0000 (000000000 00 Electronics (B2C) Toronto, Canada 0000
00. 0000000 000000 Pharmaceuticals CA
To view Australis Capital’s complete subsidiaries history, request access »